市場調查報告書
商品編碼
1375110
北美微生物纖維素市場預測至 2028 年 - COVID-19 影響和區域分析 - 按應用(食品和飲料、食品包裝、生物醫學、化妝品等)North America Microbial Cellulose Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Application (Food & Beverages, Food Packaging, Biomedical, Cosmetics, and Others) |
2022年北美微生物纖維素市場價值為64.1611億美元,預計2028年將達到124.3567億美元;預計2022年至2028年年複合成長率為11.7%。
醫療保健產業對微生物纖維素的需求不斷增加
微生物纖維素已引起生物醫學和醫療保健行業的廣泛關注。微生物纖維素是由緻密編織的3D網狀奈米纖維組成。它具有優異的水結合能力、高拉伸強度和低血栓形成性。在傷口敷料中用作人體軟組織修復材料。在嚴重燒傷的情況下,微生物纖維素可以作為極好的傷口癒合劑,因為它有助於傷口癒合和表皮再生的過程。
此外,微生物纖維素具有低過敏性、無細胞毒性和無刺激性,並且在難以觸及的傷口和損傷中表現出完美的皮膚黏附力。微生物纖維素是人造血管和心血管部件的理想材料,因為它完美適應不規則的解剖輪廓。對於糖尿病患者,微生物纖維素用於糖尿病足和靜脈潰瘍的敷料。微生物纖維素也應用於組織工程中,以製造軟骨組織植入物、角膜植入物、硬腦膜植入物和其他醫療植入物。製造商正在開發產品來滿足醫療保健和製藥業對微生物纖維素不斷成長的需求。因此,微生物纖維素在醫療保健行業的廣泛應用推動了其需求,從而促進了微生物纖維素市場的成長。
北美微生物纖維素市場概況
北美的微生物纖維素市場分為美國、加拿大和墨西哥。由於塑膠和聚合物、水泥添加劑、醫療保健、食品和飲料以及化妝品等各種最終用途行業的需求不斷增加,北美為微生物纖維素製造商提供了許多成長機會。美國食品藥物管理局 (FDA) 認為微生物纖維素是 GRAS(通常被認為是安全的)食品添加物。它用於傳統甜點、植物性肉類、低膽固醇飲食、食品/飲料添加劑、食品包裝等。北美紡織業正在進行研發活動,並與其他市場參與者合作,開發由細菌纖維素製成的環保、永續產品。例如,2022 年 5 月,總部位於加州的 von Holzhausen 公司與澳洲領先的研發公司 Nanollose 簽署了一項合作協議,以利用細菌纖維素開發下一代純素皮革。同樣,2022 年 5 月,亞什蘭全球控股公司推出了「natrathix」生物纖維素,這是一種源自天然、可生物分解的皮膚護理增稠劑。該地區主要參與者的此類舉措正在促進市場成長。
北美微生物纖維素市場收入及 2028 年預測(百萬美元)
北美微生物纖維素市場細分
北美微生物纖維素市場根據應用和國家進行細分。根據應用,北美微生物纖維素市場分為食品和飲料、食品包裝、生物醫學、化妝品等。 2022 年,食品和飲料領域佔據最大的市場。
依國家分類,北美微生物纖維素市場分為美國、加拿大和墨西哥。 2022年,美國將主導北美微生物纖維素市場。
阿什蘭公司; Axcelon 生物聚合物公司;細菌纖維素解決方案公司;纖維素實驗室公司;和 Polybion SL 是北美微生物纖維素市場的領先公司。
The North America microbial cellulose market was valued at US$ 6,416.11 million in 2022 and is expected to reach US$ 12,435.67 million by 2028; it is estimated to grow at a CAGR of 11.7% from 2022 to 2028.
Increasing Demand for Microbial Cellulose in Healthcare Industry
Microbial cellulose has gained significant attention across the biomedical & healthcare industry. Microbial cellulose is composed of a densely woven three-dimensional network nanofiber. It possesses excellent water-binding capacity, high tensile strength, and low thrombogenicity. It is used as a soft human tissue repair material in wound dressing. In cases of severe burns, microbial cellulose acts as an excellent wound-healing agent as it aids the process of wound healing and epidermal regeneration.
Moreover, microbial cellulose is hypoallergenic, noncytotoxic, and nonirritating, and shows perfect skin adhesion in hard-to-reach wounds and injuries. Microbial cellulose is an ideal material for prosthetic blood vessels and cardiovascular components since it adapts perfectly to irregular anatomical contours. For diabetic patients, microbial cellulose is used for the dressing of diabetic feet and venous ulcers. Microbial cellulose also finds application in tissue engineering to make cartilage tissue implants, cornea implants, dura implants, and other medical implants. Manufacturers are developing products that cater to the rising demand for microbial cellulose in the healthcare & pharmaceuticals industry. Thus, the widespread applications of microbial cellulose in the healthcare industry propel its demand, thereby bolstering the microbial cellulose market growth.
North America Microbial Cellulose Market Overview
The microbial cellulose market in North America is segmented into the US, Canada, and Mexico. North America holds many growth opportunities for microbial cellulose manufacturers owing to increasing demand from various end-use industries such as plastics & polymers, cement additives, healthcare, food & beverages, and cosmetics. The US Food Drugs and Administration (FDA) considers microbial cellulose a GRAS (generally recognized as safe) food additive. It is used in conventional desserts, plant-based meat, low cholesterol diet, food/beverage additives, food packaging, and others. The textile industry in North America is conducting research & development activities and collaborating with other market players to develop eco-friendly, sustainable products made from bacterial cellulose. For instance, in May 2022, von Holzhausen, a California-based company, signed a collaboration agreement with Nanollose, a leading Australia-based research and development company, to develop next-gen vegan leather from bacterial cellulose. Similarly, in May 2022, Ashland Global Holdings Inc. launched 'natrathix' bio cellulose, a nature-derived, biodegradable thickener for skin care. Such initiatives by key players in the region are contributing to the market growth.
North America Microbial Cellulose Market Revenue and Forecast to 2028 (US$ Million)
North America Microbial Cellulose Market Segmentation
The North America microbial cellulose market is segmented based on application and country. Based on application, the North America microbial cellulose market is segmented into food & beverages, food packaging, biomedical, cosmetics, and others. The food & beverages segment held the largest market share in 2022.
Based on country, the North America microbial cellulose market is segmented into the US, Canada, and Mexico. The US dominated the North America microbial cellulose market share in 2022.
Ashland Inc; Axcelon Biopolymers Corp; Bacterial Cellulose Solutions Inc; Cellulose Lab Inc; and Polybion SL are the leading companies operating in the North America microbial cellulose market.